The present paper focused on development of structural lightweight concrete by using light weight expanded clay aggregate (LECA) with unit weight of 1700 kg/m 3 to 1900 kg/m 3 and compressive strength of 40 MPa. In this study, investigation was done using LECA as coarse aggregate in concrete by replacing normal aggregate in three differing volume fractions i.e., 30%, 40% and 50% with different w/b ratios 0.40, 0.50 and 0.60 to produce lightweight expanded clay aggregate concrete (LECAC) with addition of chemical admixture. For that, concrete mix design was done using IS method and replacement of lightweight aggregate was calculated based on volume batching. The effect of mineral admixture (i.e., 10% microsilica) on the properties of lightweight expanded clay aggregate concrete and normal weight aggregate concrete such as workability of fresh concrete, compressive strength and flexural strength of concrete were compared. The studies also include the effect of elevated temperature on light weight expanded clay aggregate concrete and normal weight aggregate concrete.
Lightweight concrete can be produced by replacing the normal aggregate with lightweight aggregate either partially or fully, depending upon the requirements of density and strength. The present study covers the influence of different aggregate curing conditions and admixtures on the strength of lightweight expanded clay aggregate concrete under normal curing and vacuum curing with and without addition of silica fume. The grade of the concrete is M40. The lightweight aggregate used is LECA, an expanded clay aggregate. Investigations were carried out up to a replacement of 50% of coarse aggregate. The workability and strength at different ages are presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.